TME

Dec 01 2025HEALTH

A New Hope for Eczema Sufferers: How Dupilumab is Changing the Game

Dupilumab is a game-changer for people with severe eczema. It's the first biologic drug approved for this condition. This means it's made from living organisms, not chemicals. It works by targeting specific parts of the immune system that cause inflammation. Eczema is a long-term skin condition. It

reading time less than a minute
Dec 01 2025CRYPTO

Crypto Crash: Bitcoin Drops Below $85, 000

The crypto market is in a slump. Bitcoin, the most well-known cryptocurrency, has dropped below $85, 000. This is a big deal because just a few months ago, it was worth over $126, 000. That's a loss of about 33% in just eight weeks. This isn't just happening to Bitcoin. Other companies related to c

reading time less than a minute
Dec 01 2025CRYPTO

Crypto Market Takes a Big Hit: What's Going On?

Crypto prices have been dropping fast. Bitcoin, the most famous one, fell below $85, 000. This is a big deal because it was worth over $126, 000 just a few weeks ago. That's a loss of about a third of its value in just eight weeks. It's not just Bitcoin. Other crypto-related companies are also feel

reading time less than a minute
Dec 01 2025CRYPTO

Bitcoin's Rollercoaster: Lessons from 2019

Bitcoin's recent drop below $90, 000 has sparked conversations about what might happen next. Some experts are looking back at 2019 for clues. Back then, Bitcoin's value kept falling even after the Federal Reserve stopped tightening its monetary policy. This time around, the pattern seems eerily simi

reading time less than a minute
Dec 01 2025HEALTH

Mixing Meds and Lifestyle Changes: A Closer Look

People often wonder if combining medication with lifestyle changes is the best way to manage health conditions. One area of interest is the use of GLP-1 receptor agonists along with lifestyle modifications. These medications are commonly used to manage type 2 diabetes and obesity. They work by mimic

reading time less than a minute
Dec 01 2025HEALTH

A New Leader for U. S. Vaccine Policies

The U. S. Department of Health and Human Services made a significant change recently. They picked Kirk Milhoan, a doctor who specializes in children's heart health, to lead a key group. This group gives advice to the Centers for Disease Control and Prevention on vaccines. The group is meeting soon t

reading time less than a minute
Dec 01 2025HEALTH

A New Shot at HIV Prevention: What's the Deal with Cabotegravir?

The fight against HIV has seen a new player enter the ring: Cabotegravir, a long-acting injectable PrEP. While the usual oral PrEP has been a game-changer, it's not without its issues. Side effects, the hassle of daily pills, and the stigma around it can make it tough for people to stick with it. Th

reading time less than a minute
Dec 01 2025FINANCE

Tech Investments: A Smart Way to Earn More

Investing in tech stocks can be a great way to grow your money. Many people think that buying stocks directly is the best way to go. But there are other options that might give you better returns. One of these options is closed-end funds, or CEFs. These funds invest in a mix of stocks and pay out d

reading time less than a minute
Dec 01 2025POLITICS

The Forgotten Fight for Equal Education

After the Civil War, many smart people noticed that poor education in the South helped keep people under the control of wealthy slave owners. They thought that teaching everyone, regardless of their skin color, could help create a fairer society. This idea led to the creation of the first Department

reading time less than a minute
Dec 01 2025FINANCE

The IPO Surge: Should You Join the Rush?

The market is seeing a lot of new companies going public, and it's easy to get excited. But before you dive in, think about this: many of these stocks are in risky areas like AI and cryptocurrency. So far this year, there have been 161 IPOs in the U. S. , which is already more than last year's total

reading time less than a minute